Literature DB >> 10991829

Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.

K Poole1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10991829      PMCID： PMC90120          DOI： 10.1128/AAC.44.10.2595-2599.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  65 in total

1.  Introduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid integration.

Authors:  G W Kaatz; S M Seo; T J Foster
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

2.  Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.

Authors:  B Fournier; R Aras; D C Hooper
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

Review 3.  A structure-based mechanism for drug binding by multidrug transporters.

Authors:  E E Zheleznova; P Markham; R Edgar; E Bibi; A A Neyfakh; R G Brennan
Journal:  Trends Biochem Sci       Date:  2000-02       Impact factor: 13.807

4.  Activity of newer fluoroquinolones in vitro against gram-positive bacteria.

Authors:  G M Eliopoulos
Journal:  Drugs       Date:  1999       Impact factor: 9.546

5.  Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.

Authors:  P N Markham; E Westhaus; K Klyachko; M E Johnson; A A Neyfakh
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.

Authors:  M J Ferrándiz; J Oteo; B Aracil; J L Gómez-Garcés; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

Review 7.  Penicillin- and cephalosporin-resistant Streptococcus pneumoniae. Emerging treatment for an emerging problem.

Authors:  K P Klugman; C Feldman
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

8.  Involvement of a natural transport system in the process of efflux-mediated drug resistance in Mycobacterium smegmatis.

Authors:  S K Banerjee; K Bhatt; P Misra; P K Chakraborti
Journal:  Mol Gen Genet       Date:  2000-01

9.  The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.

Authors:  J R Aeschlimann; G W Kaatz; M J Rybak
Journal:  J Antimicrob Chemother       Date:  1999-09       Impact factor: 5.790

10.  Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.

Authors:  Isabelle Guillemin; Wladimir Sougakoff; Emmanuelle Cambau; Valérie Revel-Viravau; Nicole Moreau; Vincent Jarlier
Journal:  Microbiology       Date:  1999-09       Impact factor: 2.777
View more
  22 in total

1.  TtgV bound to a complex operator site represses transcription of the promoter for the multidrug and solvent extrusion TtgGHI pump.

Authors:  María-Eugenia Guazzaroni; Wilson Terán; Xiaodong Zhang; María-Trinidad Gallegos; Juan L Ramos
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

2.  Mobilizable IncQ-related plasmid carrying a new quinolone resistance gene, qnrS2, isolated from the bacterial community of a wastewater treatment plant.

Authors:  Gabriele Bönemann; Michael Stiens; Alfred Pühler; Andreas Schlüter
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  The secondary multidrug/proton antiporter MdfA tolerates displacements of an essential negatively charged side chain.

Authors:  Nadejda Sigal; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

5.  TtgV represses two different promoters by recognizing different sequences.

Authors:  Sandy Fillet; Marisela Vélez; Duo Lu; Xiaodong Zhang; María-Trinidad Gallegos; Juan L Ramos
Journal:  J Bacteriol       Date:  2008-12-29       Impact factor: 3.490

6.  Critical biophysical properties in the Pseudomonas aeruginosa efflux gene regulator MexR are targeted by mutations conferring multidrug resistance.

Authors:  Cecilia Andrésen; Shah Jalal; Daniel Aili; Yi Wang; Sohidul Islam; Anngelica Jarl; Bo Liedberg; Bengt Wretlind; Lars-Göran Mårtensson; Maria Sunnerhagen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

Review 7.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

8.  Analysis of a complete library of putative drug transporter genes in Escherichia coli.

Authors:  K Nishino; A Yamaguchi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

9.  Native efflux pumps contribute resistance to antimicrobials of skin and the ability of Staphylococcus aureus to colonize skin.

Authors:  Que Chi Truong-Bolduc; Regis A Villet; Zoe A Estabrooks; David C Hooper
Journal:  J Infect Dis       Date:  2013-11-26       Impact factor: 5.226

Review 10.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.